Calidi Biotherapeutics, Inc. (NYSE:CLDI) Shares Purchased by Red Wave Investments LLC

Red Wave Investments LLC raised its holdings in shares of Calidi Biotherapeutics, Inc. (NYSE:CLDI) by 74.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 80,828 shares of the company’s stock after acquiring an additional 34,367 shares during the quarter. Red Wave Investments LLC’s holdings in Calidi Biotherapeutics were worth $93,000 at the end of the most recent quarter.

Separately, Drive Wealth Management LLC purchased a new position in shares of Calidi Biotherapeutics in the 4th quarter valued at $104,000. Institutional investors own 12.53% of the company’s stock.

Calidi Biotherapeutics Stock Performance

NYSE:CLDI opened at $1.05 on Friday. The firm’s fifty day simple moving average is $1.18 and its 200 day simple moving average is $1.37. Calidi Biotherapeutics, Inc. has a twelve month low of $0.58 and a twelve month high of $16.80.

About Calidi Biotherapeutics

Calidi Biotherapeutics, Inc, a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors.